FDA clears Nurix Therapeutics, Inc.'s GS-6791 for inflammatory disorders; Nurix earns $5M milestone from Gilead. Click for my ...

Beneath the surface of the tiny, see-through worm Caenorhabditis elegans, researchers have found new clues about how certain ...

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

In a nutshell Sound waves can influence how cells behave, even affecting fat development. In lab experiments, exposing cells ...

Scientists have found a surprising new way to make certain cancer drugs work dramatically better – by helping them get inside ...

The AHA has published a scientific statement regarding cardiovascular toxicity in patients with history of treatment for childhood cancer.

Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 ...

This study is led by Prof. Kenneth To (School of Pharmacy, The Chinese University of Hong Kong) and Dr. William Cho ...

DelveInsight's "FYARRO Market Size, Forecast, and Market Insight Report" highlights the details around FYARRO, an mTOR ...